Optimizing MDMA therapy dose for PTSD in veterans
Part of Mental health clinical trials.
This trial tests different doses of MDMA (a drug sometimes called 'ecstasy') combined with therapy to see which dose works best for treating PTSD in veterans. The goal is to find a safer, more effective dose to help reduce PTSD symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a U.S. military veteran aged 18 or older.
- You need a current diagnosis of PTSD (post-traumatic stress disorder).
- You must be able to swallow pills and agree to have your therapy sessions recorded.
- You cannot have uncontrolled high blood pressure, serious heart or liver problems, or other major medical conditions that could be worsened by the study drug.
- You must not be pregnant, nursing, or planning to become pregnant during the study, and must use effective birth control if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of two investigational drugs, psilocybin and MDMA, can help veterans with post-traumatic stress disorder (PTSD). You would receive the drugs in a controlled setting and be monitored closely.
This study tests whether MDMA-assisted therapy can help veterans who have both PTSD and alcohol use disorder. If you have tried a standard therapy before and want to reduce or stop drinking, this treatment may offer a new option.
This study tests whether MDMA, given in a controlled clinical setting, can reduce symptoms of PTSD and alcohol use disorder in veterans. It also combines the medication with structured therapy sessions to help you manage symptoms without relying on alcohol or other substances.
This trial tests if MDMA-assisted therapy can help mental healthcare providers. It involves taking MDMA in a therapeutic setting while being recorded, and you must be trained in this type of therapy.
This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
Hear when a new Posttraumatic Stress Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.